Marie-laure Le Lez

Tours, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Type I interferon signature does not correlate with disease activity in Blau syndrome.

Type I interferon signature does not correlate with disease activity in Blau syndrome.

Journal: Pediatric research

Published: January 28, 2026

Three-Year Follow-Up after Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Treating Diabetic Macular Edema: The ILUVI1MOIS Study.

Three-Year Follow-Up after Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Treating Diabetic Macular Edema: The ILUVI1MOIS Study.

Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

Published: June 27, 2025

Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study.

Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study.

Journal: The British journal of ophthalmology

Published: December 27, 2023

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study.

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study.

Journal: Ophthalmology and therapy

Published: May 05, 2023

Management of binocular diplopia in the department of ophthalmic emergencies at the Regional University Hospital of Tours

Management of binocular diplopia in the department of ophthalmic emergencies at the Regional University Hospital of Tours

Journal: Journal francais d'ophtalmologie

Published: September 12, 2022

ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema.

ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: March 27, 2021

Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.

Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.

Journal: American journal of hematology

Published: December 29, 2020

Calcium oxalate crystals retinopathy following domino liver transplant: A case report.

Calcium oxalate crystals retinopathy following domino liver transplant: A case report.

Journal: European journal of ophthalmology

Published: August 20, 2020

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.

Journal: Blood

Published: March 04, 2020

Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.

Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.

Journal: Trials

Published: October 18, 2019

ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis.

ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis.

Journal: Ophthalmology

Published: December 24, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026